{"id":38504,"date":"2018-01-16T00:00:00","date_gmt":"2018-01-15T23:00:00","guid":{"rendered":"http:\/\/www.pcb.ub.edu\/\/alianza-entre-chemotargets-y-el-centro-de-evaluacion-e-investigacion-de-medicamentos-de-la-fda\/"},"modified":"2020-11-16T16:20:22","modified_gmt":"2020-11-16T15:20:22","slug":"alianza-entre-chemotargets-y-el-centro-de-evaluacion-e-investigacion-de-medicamentos-de-la-fda","status":"publish","type":"post","link":"https:\/\/www.pcb.ub.edu\/es\/alianza-entre-chemotargets-y-el-centro-de-evaluacion-e-investigacion-de-medicamentos-de-la-fda\/","title":{"rendered":"Alianza entre Chemotargets y el Centro de Evaluaci\u00f3n e Investigaci\u00f3n de Medicamentos de la FDA"},"content":{"rendered":"<p>El objetivo principal de este convenio de investigaci\u00f3n ser\u00e1 evaluar la utilidad y rendimiento de la plataforma de inteligencia y descubrimiento\u00a0Chemotargets <a href=\"https:\/\/www.chemotargets.com\/PRODUCTS\/CLARITY-v4\" target=\"_blank\" rel=\"noopener noreferrer\">CLARITY<sup>\u00ae<\/sup><\/a>\u00a0en la predicci\u00f3n de actividades espec\u00edficas y no espec\u00edficas, usando datos farmacol\u00f3gicos y de seguridad conocidos obtenidos en estudios experimentales de entidades moleculares peque\u00f1as.<\/p>\n<p>El CDER est\u00e1 interesado en la evaluaci\u00f3n de modelos <em>in silico <\/em>para determinar los perfiles farmacol\u00f3gicos a fin de predecir los posibles acontecimientos adversos de los medicamentos en desarrollo. Por otro lado, el conocimiento del perfil de diana molecular de una sustancia qu\u00edmica puede ayudar a predecir su potencial de abuso y adicci\u00f3n, lo que permitir\u00eda reducir los riesgos asociados a la exposici\u00f3n a esa sustancia.<\/p>\n<p>La colaboraci\u00f3n incluir\u00e1 el uso de la plataforma CLARITY<sup>\u00ae<\/sup> de Chemotargets para evaluar hip\u00f3tesis sobre los par\u00e1metros toxicol\u00f3gicos que usa el CDER en las evaluaciones de seguridad de los medicamentos. El programa identifica las posibles dianas moleculares y modo de acci\u00f3n de mol\u00e9culas peque\u00f1as y sus metabolitos predichos mediante un screening r\u00e1pido y simult\u00e1neo, en \u00fanico modelo predictivo, de m\u00e1s de 2000 mecanismos de acci\u00f3n asociados con la actividad terap\u00e9utica y criterios de seguridad, entre los que se incluyen cientos de mecanismos de acci\u00f3n relacionados con la seguridad anotados con informaci\u00f3n sobre toxicidad precl\u00ednica y efectos adversos cl\u00ednicos.\u00a0<\/p>\n<p>En este sentido, CLARITY<sup>\u00ae<\/sup>\u00a0 permite predecir la seguridad de un compuesto a trav\u00e9s del tratamiento meticuloso de datos FAERS (un sistema para informar sobre acontecimientos adversos de la FDA) y del uso de descriptores matem\u00e1ticos que distinguen las se\u00f1ales de seguridad del ruido de fondo. El CDER tendr\u00e1 acceso a una versi\u00f3n de la plataforma basada en un conjunto de entrenamiento debidamente seleccionado, obtenido a partir de recursos internos as\u00ed como de datos de patentes de la base de datos GOSTAR creada por Excelra, a fin de asegurar una extensa cobertura del espacio qu\u00edmico. La aplicaci\u00f3n Marvin JS de Chemaxon proporciona la capacidad de dise\u00f1o de estructuras qu\u00edmicas.<\/p>\n<p>\u25ba <strong><a href=\"http:\/\/www.pcb.ub.edu\/portal\/es\/noticies\/-\/noticia\/not_prous-institute-signa-un-acord-d-inversio-amb-chemotargets?inheritRedirect=false&amp;redirect=%2Fportal%2Fen%2Fcerca%3Fp_p_id%3Dcercador_WAR_empleatsempresesportlet%26p_p_lifecycle%3D0%26p_p_state%3Dnormal%26p_p_mode%3Dview%26p_p_col_id%3Dcolumn-1%26p_p_col_count%3D1%26_cercador_WAR_empleatsempresesportlet_keywords%3Dchemotargets%26_cercador_WAR_empleatsempresesportlet_tab%3D3&amp;backURL=%2Fportal%2Fen%2Fcerca%3Fp_p_id%3Dcercador_WAR_empleatsempresesportlet%26p_p_lifecycle%3D0%26p_p_state%3Dnormal%26p_p_mode%3Dview%26p_p_col_id%3Dcolumn-1%26p_p_col_count%3D1%26_cercador_WAR_empleatsempresesportlet_keywords%3Dchemotargets%26_cercador_WAR_empleatsempresesportlet_tab%3D3\" target=\"_blank\" rel=\"noopener noreferrer\">Noticia relacionada [+]<\/a><\/strong><\/p>\n<p>\u00a0<\/p>\n","protected":false},"excerpt":{"rendered":"<p>El Centro de Evaluaci\u00f3n e Investigaci\u00f3n de Medicamentos de la FDA\u00a0(<a href=\"https:\/\/www.fda.gov\/AboutFDA\/CentersOffices\/OfficeofMedicalProductsandTobacco\/CDER\/default.htm\" target=\"_blank\" rel=\"noopener noreferrer\">FDA\u2013CDER<\/a>) y\u00a0<a href=\"http:\/\/www.pcb.ub.edu\/portal\/es\/cerca?p_p_id=cercador_WAR_empleatsempresesportlet&amp;p_p_lifecycle=0&amp;p_p_state=maximized&amp;p_p_mode=view&amp;p_p_col_id=column-1&amp;p_p_col_count=1&amp;_cercador_WAR_empleatsempresesportlet_jspPage=%2Fhtml%2Fcommon%2Fdetall-empresa.jsp&amp;_cercador_WAR_empleatsempresesportlet_empresaId=ENT_006013&amp;_cercador_WAR_empleatsempresesportlet_redirect=%2Fportal%2Fca%2Fcerca%3Fp_p_id%3Dcercador_WAR_empleatsempresesportlet%26p_p_lifecycle%3D0%26p_p_state%3Dnormal%26p_p_mode%3Dview%26p_p_col_id%3Dcolumn-1%26p_p_col_count%3D1%26_cercador_WAR_empleatsempresesportlet_keywords%3Dchemotargets%26_cercador_WAR_empleatsempresesportlet_tab%3D1\" target=\"_blank\" rel=\"noopener noreferrer\">Chemotargets<\/a>\u00a0\u2013una<em>\u00a0spin-off\u00a0<\/em>del\u00a0Instituto Hospital del Mar de Investigaciones M\u00e9dicas (IMIM)\u00a0con sede en el Parc Cient\u00edfic\u00a0de Barcelona (PCB)\u2013\u00a0trabajar\u00e1n de forma conjunta en virtud de un Convenio de colaboraci\u00f3n en investigaci\u00f3n de cinco a\u00f1os de duraci\u00f3n.\u00a0La finalidad de esta colaboraci\u00f3n es mejorar las evaluaciones de seguridad de los medicamentos de uso humano.<\/p>\n<p>\u00a0<\/p>\n","protected":false},"author":1,"featured_media":24530,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"footnotes":""},"categories":[9],"tags":[],"class_list":["post-38504","post","type-post","status-publish","format-standard","has-post-thumbnail","category-sin-categorizar"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Alianza entre Chemotargets y el Centro de Evaluaci\u00f3n e Investigaci\u00f3n de Medicamentos de la FDA - Parc Cient\u00edfic de Barcelona<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.pcb.ub.edu\/es\/alianza-entre-chemotargets-y-el-centro-de-evaluacion-e-investigacion-de-medicamentos-de-la-fda\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Alianza entre Chemotargets y el Centro de Evaluaci\u00f3n e Investigaci\u00f3n de Medicamentos de la FDA - Parc Cient\u00edfic de Barcelona\" \/>\n<meta property=\"og:description\" content=\"El Centro de Evaluaci\u00f3n e Investigaci\u00f3n de Medicamentos de la FDA\u00a0(FDA\u2013CDER) y\u00a0Chemotargets\u00a0\u2013una\u00a0spin-off\u00a0del\u00a0Instituto Hospital del Mar de Investigaciones M\u00e9dicas (IMIM)\u00a0con sede en el Parc Cient\u00edfic\u00a0de Barcelona (PCB)\u2013\u00a0trabajar\u00e1n de forma conjunta en virtud de un Convenio de colaboraci\u00f3n en investigaci\u00f3n de cinco a\u00f1os de duraci\u00f3n.\u00a0La finalidad de esta colaboraci\u00f3n es mejorar las evaluaciones de seguridad de los medicamentos de uso humano. \u00a0\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.pcb.ub.edu\/es\/alianza-entre-chemotargets-y-el-centro-de-evaluacion-e-investigacion-de-medicamentos-de-la-fda\/\" \/>\n<meta property=\"og:site_name\" content=\"Parc Cient\u00edfic de Barcelona\" \/>\n<meta property=\"article:published_time\" content=\"2018-01-15T23:00:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2020-11-16T15:20:22+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.pcb.ub.edu\/wp-content\/uploads\/2018\/01\/16049214945fa928965a0f7.jpeg\" \/>\n\t<meta property=\"og:image:width\" content=\"800\" \/>\n\t<meta property=\"og:image:height\" content=\"438\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"adminpcb\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"adminpcb\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/alianza-entre-chemotargets-y-el-centro-de-evaluacion-e-investigacion-de-medicamentos-de-la-fda\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/alianza-entre-chemotargets-y-el-centro-de-evaluacion-e-investigacion-de-medicamentos-de-la-fda\\\/\"},\"author\":{\"name\":\"adminpcb\",\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/#\\\/schema\\\/person\\\/d13cab05cd0a75b17fddca8496481021\"},\"headline\":\"Alianza entre Chemotargets y el Centro de Evaluaci\u00f3n e Investigaci\u00f3n de Medicamentos de la FDA\",\"datePublished\":\"2018-01-15T23:00:00+00:00\",\"dateModified\":\"2020-11-16T15:20:22+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/alianza-entre-chemotargets-y-el-centro-de-evaluacion-e-investigacion-de-medicamentos-de-la-fda\\\/\"},\"wordCount\":373,\"image\":{\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/alianza-entre-chemotargets-y-el-centro-de-evaluacion-e-investigacion-de-medicamentos-de-la-fda\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.pcb.ub.edu\\\/wp-content\\\/uploads\\\/2018\\\/01\\\/16049214945fa928965a0f7.jpeg\",\"articleSection\":[\"Sin categorizar\"],\"inLanguage\":\"es\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/alianza-entre-chemotargets-y-el-centro-de-evaluacion-e-investigacion-de-medicamentos-de-la-fda\\\/\",\"url\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/alianza-entre-chemotargets-y-el-centro-de-evaluacion-e-investigacion-de-medicamentos-de-la-fda\\\/\",\"name\":\"Alianza entre Chemotargets y el Centro de Evaluaci\u00f3n e Investigaci\u00f3n de Medicamentos de la FDA - Parc Cient\u00edfic de Barcelona\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/alianza-entre-chemotargets-y-el-centro-de-evaluacion-e-investigacion-de-medicamentos-de-la-fda\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/alianza-entre-chemotargets-y-el-centro-de-evaluacion-e-investigacion-de-medicamentos-de-la-fda\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.pcb.ub.edu\\\/wp-content\\\/uploads\\\/2018\\\/01\\\/16049214945fa928965a0f7.jpeg\",\"datePublished\":\"2018-01-15T23:00:00+00:00\",\"dateModified\":\"2020-11-16T15:20:22+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/#\\\/schema\\\/person\\\/d13cab05cd0a75b17fddca8496481021\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/alianza-entre-chemotargets-y-el-centro-de-evaluacion-e-investigacion-de-medicamentos-de-la-fda\\\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/alianza-entre-chemotargets-y-el-centro-de-evaluacion-e-investigacion-de-medicamentos-de-la-fda\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/alianza-entre-chemotargets-y-el-centro-de-evaluacion-e-investigacion-de-medicamentos-de-la-fda\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.pcb.ub.edu\\\/wp-content\\\/uploads\\\/2018\\\/01\\\/16049214945fa928965a0f7.jpeg\",\"contentUrl\":\"https:\\\/\\\/www.pcb.ub.edu\\\/wp-content\\\/uploads\\\/2018\\\/01\\\/16049214945fa928965a0f7.jpeg\",\"width\":800,\"height\":438},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/alianza-entre-chemotargets-y-el-centro-de-evaluacion-e-investigacion-de-medicamentos-de-la-fda\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Alianza entre Chemotargets y el Centro de Evaluaci\u00f3n e Investigaci\u00f3n de Medicamentos de la FDA\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/#website\",\"url\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/\",\"name\":\"Parc Cient\u00edfic de Barcelona\",\"description\":\"Universitat de Barcelona\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/#\\\/schema\\\/person\\\/d13cab05cd0a75b17fddca8496481021\",\"name\":\"adminpcb\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/41ad0fab4bb3bf5348b0af9612159cfd93173a57bbca98fecb50fa6f3ab97d28?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/41ad0fab4bb3bf5348b0af9612159cfd93173a57bbca98fecb50fa6f3ab97d28?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/41ad0fab4bb3bf5348b0af9612159cfd93173a57bbca98fecb50fa6f3ab97d28?s=96&d=mm&r=g\",\"caption\":\"adminpcb\"},\"url\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/author\\\/adminpcb\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Alianza entre Chemotargets y el Centro de Evaluaci\u00f3n e Investigaci\u00f3n de Medicamentos de la FDA - Parc Cient\u00edfic de Barcelona","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.pcb.ub.edu\/es\/alianza-entre-chemotargets-y-el-centro-de-evaluacion-e-investigacion-de-medicamentos-de-la-fda\/","og_locale":"es_ES","og_type":"article","og_title":"Alianza entre Chemotargets y el Centro de Evaluaci\u00f3n e Investigaci\u00f3n de Medicamentos de la FDA - Parc Cient\u00edfic de Barcelona","og_description":"El Centro de Evaluaci\u00f3n e Investigaci\u00f3n de Medicamentos de la FDA\u00a0(FDA\u2013CDER) y\u00a0Chemotargets\u00a0\u2013una\u00a0spin-off\u00a0del\u00a0Instituto Hospital del Mar de Investigaciones M\u00e9dicas (IMIM)\u00a0con sede en el Parc Cient\u00edfic\u00a0de Barcelona (PCB)\u2013\u00a0trabajar\u00e1n de forma conjunta en virtud de un Convenio de colaboraci\u00f3n en investigaci\u00f3n de cinco a\u00f1os de duraci\u00f3n.\u00a0La finalidad de esta colaboraci\u00f3n es mejorar las evaluaciones de seguridad de los medicamentos de uso humano. \u00a0","og_url":"https:\/\/www.pcb.ub.edu\/es\/alianza-entre-chemotargets-y-el-centro-de-evaluacion-e-investigacion-de-medicamentos-de-la-fda\/","og_site_name":"Parc Cient\u00edfic de Barcelona","article_published_time":"2018-01-15T23:00:00+00:00","article_modified_time":"2020-11-16T15:20:22+00:00","og_image":[{"width":800,"height":438,"url":"https:\/\/www.pcb.ub.edu\/wp-content\/uploads\/2018\/01\/16049214945fa928965a0f7.jpeg","type":"image\/jpeg"}],"author":"adminpcb","twitter_card":"summary_large_image","twitter_misc":{"Escrito por":"adminpcb","Tiempo de lectura":"2 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.pcb.ub.edu\/es\/alianza-entre-chemotargets-y-el-centro-de-evaluacion-e-investigacion-de-medicamentos-de-la-fda\/#article","isPartOf":{"@id":"https:\/\/www.pcb.ub.edu\/es\/alianza-entre-chemotargets-y-el-centro-de-evaluacion-e-investigacion-de-medicamentos-de-la-fda\/"},"author":{"name":"adminpcb","@id":"https:\/\/www.pcb.ub.edu\/es\/#\/schema\/person\/d13cab05cd0a75b17fddca8496481021"},"headline":"Alianza entre Chemotargets y el Centro de Evaluaci\u00f3n e Investigaci\u00f3n de Medicamentos de la FDA","datePublished":"2018-01-15T23:00:00+00:00","dateModified":"2020-11-16T15:20:22+00:00","mainEntityOfPage":{"@id":"https:\/\/www.pcb.ub.edu\/es\/alianza-entre-chemotargets-y-el-centro-de-evaluacion-e-investigacion-de-medicamentos-de-la-fda\/"},"wordCount":373,"image":{"@id":"https:\/\/www.pcb.ub.edu\/es\/alianza-entre-chemotargets-y-el-centro-de-evaluacion-e-investigacion-de-medicamentos-de-la-fda\/#primaryimage"},"thumbnailUrl":"https:\/\/www.pcb.ub.edu\/wp-content\/uploads\/2018\/01\/16049214945fa928965a0f7.jpeg","articleSection":["Sin categorizar"],"inLanguage":"es"},{"@type":"WebPage","@id":"https:\/\/www.pcb.ub.edu\/es\/alianza-entre-chemotargets-y-el-centro-de-evaluacion-e-investigacion-de-medicamentos-de-la-fda\/","url":"https:\/\/www.pcb.ub.edu\/es\/alianza-entre-chemotargets-y-el-centro-de-evaluacion-e-investigacion-de-medicamentos-de-la-fda\/","name":"Alianza entre Chemotargets y el Centro de Evaluaci\u00f3n e Investigaci\u00f3n de Medicamentos de la FDA - Parc Cient\u00edfic de Barcelona","isPartOf":{"@id":"https:\/\/www.pcb.ub.edu\/es\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.pcb.ub.edu\/es\/alianza-entre-chemotargets-y-el-centro-de-evaluacion-e-investigacion-de-medicamentos-de-la-fda\/#primaryimage"},"image":{"@id":"https:\/\/www.pcb.ub.edu\/es\/alianza-entre-chemotargets-y-el-centro-de-evaluacion-e-investigacion-de-medicamentos-de-la-fda\/#primaryimage"},"thumbnailUrl":"https:\/\/www.pcb.ub.edu\/wp-content\/uploads\/2018\/01\/16049214945fa928965a0f7.jpeg","datePublished":"2018-01-15T23:00:00+00:00","dateModified":"2020-11-16T15:20:22+00:00","author":{"@id":"https:\/\/www.pcb.ub.edu\/es\/#\/schema\/person\/d13cab05cd0a75b17fddca8496481021"},"breadcrumb":{"@id":"https:\/\/www.pcb.ub.edu\/es\/alianza-entre-chemotargets-y-el-centro-de-evaluacion-e-investigacion-de-medicamentos-de-la-fda\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.pcb.ub.edu\/es\/alianza-entre-chemotargets-y-el-centro-de-evaluacion-e-investigacion-de-medicamentos-de-la-fda\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.pcb.ub.edu\/es\/alianza-entre-chemotargets-y-el-centro-de-evaluacion-e-investigacion-de-medicamentos-de-la-fda\/#primaryimage","url":"https:\/\/www.pcb.ub.edu\/wp-content\/uploads\/2018\/01\/16049214945fa928965a0f7.jpeg","contentUrl":"https:\/\/www.pcb.ub.edu\/wp-content\/uploads\/2018\/01\/16049214945fa928965a0f7.jpeg","width":800,"height":438},{"@type":"BreadcrumbList","@id":"https:\/\/www.pcb.ub.edu\/es\/alianza-entre-chemotargets-y-el-centro-de-evaluacion-e-investigacion-de-medicamentos-de-la-fda\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.pcb.ub.edu\/es\/"},{"@type":"ListItem","position":2,"name":"Alianza entre Chemotargets y el Centro de Evaluaci\u00f3n e Investigaci\u00f3n de Medicamentos de la FDA"}]},{"@type":"WebSite","@id":"https:\/\/www.pcb.ub.edu\/es\/#website","url":"https:\/\/www.pcb.ub.edu\/es\/","name":"Parc Cient\u00edfic de Barcelona","description":"Universitat de Barcelona","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.pcb.ub.edu\/es\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Person","@id":"https:\/\/www.pcb.ub.edu\/es\/#\/schema\/person\/d13cab05cd0a75b17fddca8496481021","name":"adminpcb","image":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/secure.gravatar.com\/avatar\/41ad0fab4bb3bf5348b0af9612159cfd93173a57bbca98fecb50fa6f3ab97d28?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/41ad0fab4bb3bf5348b0af9612159cfd93173a57bbca98fecb50fa6f3ab97d28?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/41ad0fab4bb3bf5348b0af9612159cfd93173a57bbca98fecb50fa6f3ab97d28?s=96&d=mm&r=g","caption":"adminpcb"},"url":"https:\/\/www.pcb.ub.edu\/es\/author\/adminpcb\/"}]}},"_links":{"self":[{"href":"https:\/\/www.pcb.ub.edu\/es\/wp-json\/wp\/v2\/posts\/38504","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.pcb.ub.edu\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.pcb.ub.edu\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.pcb.ub.edu\/es\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.pcb.ub.edu\/es\/wp-json\/wp\/v2\/comments?post=38504"}],"version-history":[{"count":1,"href":"https:\/\/www.pcb.ub.edu\/es\/wp-json\/wp\/v2\/posts\/38504\/revisions"}],"predecessor-version":[{"id":44632,"href":"https:\/\/www.pcb.ub.edu\/es\/wp-json\/wp\/v2\/posts\/38504\/revisions\/44632"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.pcb.ub.edu\/es\/wp-json\/wp\/v2\/media\/24530"}],"wp:attachment":[{"href":"https:\/\/www.pcb.ub.edu\/es\/wp-json\/wp\/v2\/media?parent=38504"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.pcb.ub.edu\/es\/wp-json\/wp\/v2\/categories?post=38504"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.pcb.ub.edu\/es\/wp-json\/wp\/v2\/tags?post=38504"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}